0001214659-22-010296.txt : 20220816
0001214659-22-010296.hdr.sgml : 20220816
20220816161553
ACCESSION NUMBER: 0001214659-22-010296
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220812
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARTER BRUCE L A
CENTRAL INDEX KEY: 0001225503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 221170351
MAIL ADDRESS:
STREET 1: C/O ZYMOGENETICS, INC.
STREET 2: 1201 EASTLAKE AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-56893.xml
PRIMARY DOCUMENT
X0306
4
2022-08-12
0001576263
Mirati Therapeutics, Inc.
MRTX
0001225503
CARTER BRUCE L A
C/O MIRATI THERAPEUTICS, INC
3545 CRAY COURT
SAN DIEGO
CA
92121
true
false
false
false
Common Stock
2022-08-12
4
M
false
10000
27.00
A
16021
D
Common Stock
2022-08-12
4
S
false
5107
85.0376
D
10914
D
Common Stock
2022-08-12
4
S
false
4893
85.962
D
6021
D
Non Qualified Stock Option (right to buy)
27.00
2022-08-12
4
M
false
10000
0.00
D
2028-01-17
Common Stock
10000
0
D
This transaction was executed in multiple trades at prices ranging from $84.55 to $85.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $85.60 to $86.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the Option vested and became exercisable in 12 equal monthly installments following the date of grant.
/s/Reena Desai, Attorney-in-Fact
2022-08-16